Free Trial

Nature's Sunshine Products (NATR) Stock Price, News & Analysis

Nature's Sunshine Products logo
$15.75 -0.27 (-1.69%)
As of 04:00 PM Eastern

About Nature's Sunshine Products Stock (NASDAQ:NATR)

Key Stats

Today's Range
$15.69
$16.23
50-Day Range
$12.28
$16.02
52-Week Range
$10.81
$18.06
Volume
82,552 shs
Average Volume
51,309 shs
Market Capitalization
$290.75 million
P/E Ratio
29.72
Dividend Yield
N/A
Price Target
$18.33
Consensus Rating
Buy

Company Overview

Nature's Sunshine Products Stock Analysis - MarketRank™

See Top-Rated MarketRank™ Stocks
37th Percentile Overall Score

NATR MarketRank™: 

Nature's Sunshine Products scored higher than 37% of companies evaluated by MarketBeat, and ranked 687th out of 922 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

  • Consensus Rating

    Nature's Sunshine Products has received a consensus rating of Buy. The company's average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.

  • Amount of Analyst Coverage

    Nature's Sunshine Products has only been the subject of 1 research reports in the past 90 days.

  • Read more about Nature's Sunshine Products' stock forecast and price target.
  • Price to Earnings Ratio vs. the Market

    The P/E ratio of Nature's Sunshine Products is 29.72, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 25.93.

  • Price to Earnings Ratio vs. Sector

    The P/E ratio of Nature's Sunshine Products is 29.72, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 27.00.

  • Price to Book Value per Share Ratio

    Nature's Sunshine Products has a P/B Ratio of 1.81. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

  • Read more about Nature's Sunshine Products' valuation and earnings.
  • Percentage of Shares Shorted

    0.86% of the float of Nature's Sunshine Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Nature's Sunshine Products has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nature's Sunshine Products has recently increased by 56.16%, indicating that investor sentiment is decreasing significantly.
  • Dividend Yield

    Nature's Sunshine Products does not currently pay a dividend.

  • Dividend Growth

    Nature's Sunshine Products does not have a long track record of dividend growth.

  • Percentage of Shares Shorted

    0.86% of the float of Nature's Sunshine Products has been sold short.
  • Short Interest Ratio / Days to Cover

    Nature's Sunshine Products has a short interest ratio ("days to cover") of 1.9, which is generally considered an acceptable ratio of short interest to trading volume.
  • Change versus previous month

    Short interest in Nature's Sunshine Products has recently increased by 56.16%, indicating that investor sentiment is decreasing significantly.
  • News Sentiment

    Nature's Sunshine Products has a news sentiment score of 1.88. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.57 average news sentiment score of Medical companies.
  • News Coverage This Week

    MarketBeat has tracked 1 news article for Nature's Sunshine Products this week, compared to 2 articles on an average week.
  • Insider Buying vs. Insider Selling

    In the past three months, Nature's Sunshine Products insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $32,713,796.00 in company stock.

  • Percentage Held by Insiders

    Only 5.60% of the stock of Nature's Sunshine Products is held by insiders.

  • Percentage Held by Institutions

    79.40% of the stock of Nature's Sunshine Products is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

  • Read more about Nature's Sunshine Products' insider trading history.
Receive NATR Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Nature's Sunshine Products and its competitors with MarketBeat's FREE daily newsletter.

NATR Stock News Headlines

Forget Nvidia, This “Ghost Town” Company Holds the Key to the AI Boom
Cold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to investigate this crazy Cold War story… Because it could hold the key to the entire $100 trillion AI boom. It involves an American ghost town with just 30 people… And a new twist to the AI boom that could make a lot of people rich.
See More Headlines

NATR Stock Analysis - Frequently Asked Questions

Nature's Sunshine Products' stock was trading at $14.66 at the beginning of the year. Since then, NATR stock has increased by 7.4% and is now trading at $15.75.

Nature's Sunshine Products, Inc. (NASDAQ:NATR) announced its earnings results on Tuesday, May, 6th. The company reported $0.25 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.16 by $0.09. The company earned $113.25 million during the quarter, compared to analyst estimates of $109.39 million. Nature's Sunshine Products had a net margin of 2.22% and a trailing twelve-month return on equity of 6.98%.
Read the conference call transcript
.

Shares of NATR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that Nature's Sunshine Products investors own include NVIDIA (NVDA), Broadcom (AVGO), Arista Networks (ANET), e.l.f. Beauty (ELF), Jabil (JBL), Meta Platforms (META) and Disc Medicine (IRON).

Company Calendar

Last Earnings
5/06/2025
Today
7/08/2025
Next Earnings (Estimated)
8/06/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
MED - DRUGS
Sub-Industry
Personal Products
Current Symbol
NASDAQ:NATR
CIK
275053
Employees
850
Year Founded
N/A

Price Target and Rating

High Price Target
$19.00
Low Price Target
$18.00
Potential Upside/Downside
+16.4%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
3 Analysts

Profitability

Trailing P/E Ratio
29.72
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$7.70 million
Pretax Margin
4.57%

Debt

Sales & Book Value

Annual Sales
$454.36 million
Cash Flow
$1.26 per share
Price / Cash Flow
12.48
Book Value
$8.71 per share
Price / Book
1.81

Miscellaneous

Free Float
17,429,000
Market Cap
$290.75 million
Optionable
Optionable
Beta
1.14
7 AI Stocks to Invest in Today: Capitalizing on AI and Tech Trends in 2025 Cover

Discover the top 7 AI stocks to invest in right now. This exclusive report highlights the companies leading the AI revolution and shaping the future of technology in 2025.

Get This Free Report

This page (NASDAQ:NATR) was last updated on 7/8/2025 by MarketBeat.com Staff
From Our Partners